From Brian Payne I hope everyone had a great time

New Post Public Reply Private Reply Replies (2) Message Board
danwayu2
2,104
From Brian Payne

I hope everyone had a great time celebrating Canada Day and Independence Day over the past week. With all that is going on in the world, it is a blessing to live in a part of the world where neighbours celebrate each other. Let me get a couple of things out of the way:



1. We had no idea that there was a deal in place to sell the assets of Creative Edge Nutrition, Inc. to Fresh Promise Foods. Based on all the public data and messaging coming from James, it seemed that nothing was happening and he was still trying to launch Giddy Up before “Cold Beverage Season”. I can now see that the last few statement he has made are incorrect or untruthful.

2. After promising to launch a drink over and over, we now find out that we are going to launch a Giddy Up branded pre workout powder, which will make it one of 5,000 on the open market.

3. The share structure in this 1:1 deal will create an even bigger mess than we have seen with FITX. Personally, I can’t see FINRA allowing such a structure, but things have surprised me a lot lately.

4. I think the idea of vending shareholders into a new vehicle to restore value and confidence is a step in the right direction, but why do it with a ticker that is ALSO in Skull & Crossbones Grey Market. Why not vend into a clean company that can get trading quickly (FYI, that is our plan…we have the ticker ready).

Again, where’s the drink?

5. The Asset Purchase Agreement is one thing to announce, but to get it to a point where it allowed by FINRA or OTC is questionable.

6. The timing on this seems to be coincidental to our pushing James out of FITX. By moving the assets, we have no claim to Giddy Up or any of the other IP, just a broken, empty, toxic shell.

As we stated last week, a Demand Letter was sent to James Robinson outlining the reasons behind our action and our expectations. James had until the end of day on July 5 to respond and has failed to answer any questions we posed. As a consequence to his inaction, we are prepared to proceed to the next step of filing both criminal and civil charges against James Robinson. The following is an unedited copy of the demand letter, filed on behalf of the debt holders and to the benefit of all shareholders.



*********************

Debt Holders of Creative Edge Nutrition Inc.

c/o Brian S. Payne





June 28, 2017



James Robinson

Chief Executive Officer of Creative Edge Nutrition, Inc.

8306 WILSHIRE BLVD STE #1674

Beverly Hills, CA 90211



- And –



URS Agents, LLC.

4625 West Nevso Dr. Ste. 2 & 3

Las Vegas, Nevada 89103



Re: Demand For James Robinson to Resign as an Officer and Director of Creative Edge Nutrition

Dear Mr. Robinson:

This letter shall serve as a demand on behalf of myself and the four (4) major debt holders (and significant shareholders) of Creative Edge Nutrition, Inc., myself, David Wiser, Daniel Payne and The Estate of Todd Thomas (these individuals are hereafter collectively referred to as the “Group”) for you to step aside as an Officer and Director of Creative Edge Nutrition due to your fraudulent and ultra vires conduct and refusal to act in the best interests of the corporation, its creditors and its shareholders. Since you have become an officer and director of Creative Edge, you have refused to comply with, and perform, your duties as the Chief Executive Officer of Creative Edge. The purpose of this Demand is; 1) for you to step aside and resign as the Chief Executive Officer (and any other office you may hold at Creative Edge, and 2) to take control of the company in order to stop the downward spiral the company has taken since you took office on January 1, 2015.

Nevada state statute, NRS 78.138, identifies the duties of Officer’s and Directors and their liability to the corporation and its shareholders. Directors and officers shall exercise their powers in good faith and with a view to the interests of the corporation. In exercising their respective powers, Officers and Directors, should do so with a view to the interests of the corporation, should consider: the long-term as well as short-term interests of the corporation and its stockholders, including the possibility that these interests may be best served by the continued independence of the corporation. A director or officer is individually liable to the corporation or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer where the act or failure to act constituted a breach of his or her fiduciary duties as a director or officer; and the breach of those duties involved intentional misconduct, fraud or a knowing violation of law. Reckless conduct satisfies the intent prong.

Nevada law defines breach of fiduciary duty as “… any relation existing between parties to a transaction wherein one of the parties is in duty bound to act with the utmost good faith for the benefit of the other party. A fiduciary relationship is deemed to exist when one party is bound to act for the benefit of the other party.

Pursuant to Nevada law, such a relationship imposes a duty of utmost good faith to the corporation, its shareholders and its creditors. [See, Hoopes v. Hammargren, 725 P. 2d 238 (Nev. 1986)].Generally, Officers and Directors of a corporation have a fiduciary duty to the corporation, its shareholders and even its creditors (hereafter collectively referred to herein as the “Fiduciaries”). A failure to act in the best interests of the Fiduciaries is a violation of the fiduciary duty.

Since you took office on or about January 1, 2015, you have committed numerous breaches of your fiduciary duty and perpetrated frauds against the Fiduciaries. Some of these specific instances of misconduct are as follows:

1. You have misappropriated investment funds.

Between April 1, 2016 and May 25, 2016, you were wired over One Hundred Thirty Thousand Dollars ($130,000.00 hereafter the “Investment”) to complete the production and distribution of the “Giddy Up” drink. In fact, these funds were wired to the Creative Edge corporate account with the intent that the entire Investment be used to produce and distribute the Giddy Up drink. Specifically, $20,000 from Daniel and Brian Payne was to be used to pay OTC Markets, the Secretary of State of Nevada and the Company Accountant. As well, the $60,000 from David Wiser was intended to “produce cans and an initial production run of finished product.” To date nothing has been produced or distributed, and upon information and belief, the funds have disappeared. Simply put, such conduct is not only misappropriation of investment funds but embezzlement, fraudulent inducement and unjust enrichment.

2. You have misrepresented the facts in press releases.

Although you have generally failed to keep the public and shareholders apprised of the company’s status, the few press releases you released contained numerous misrepresentations. On February 17, 2015, you caused a press release to be posted to the public announcing that “the initial flavors and packaging for its Giddy Up line of energy drinks.” However, that was misrepresentationto the public and the Fiduciaries, where two years and four months later, nothing has transpired with this supposed “company saving” drink. You also represented in that press release that; “ he Company has strong celebrity endorsers and sponsorships lined up to support the product launch”. To this date, contrary to your press released representations, no evidence of any such endorsements, let alone the drink distribution, are present, thus, this can only be deemed another misrepresentation.

On November 22, 2016 you posted a press release that represented the following: “[w]e are pleased to announce that we are in the final phase of completion with FINRA/SEC compliance. We are looking forward to Creative Edge Nutrition’s OTC market status to be reinstated very soon”. As of June 10, 2017, no such FINRA/SEC compliance had been performed or announced; yet another misrepresentation. In fact, in the November 22nd press release you essentially admit that the previous projections and representations as to the drink’s distribution were untrue or “failed to manifest”.

On February 24, 2017 you put out a press release stating that you were having “key” meetings with Dr. Pepper-Snapple Group regarding the production and distribution schedule. That press release specifically represents that, “[a] full report on my meeting outcomes, FINRA update and our Marketing/Promotional& Distribution plans for GIDDY UP'S product launch will be posted in early March 2017”. As of June 28, 2017, no such report about, meetings, FINRA or Distribution has been posted or press released. This is yet another misrepresentation to the Fiduciaries and the public.

3. You Refused to make the necessary Annual (and other) Filings with the Nevada Secretary of State’s Office allowing Creative Edge to be Administrative Dissolved.

Your refusal to make the necessary filings with the Nevada Secretary of State’s Office as well as FINRA and the SEC, resulted in the administrative dissolution of the company. You put Creative Edge in serious peril by allowing it to be administratively dissolved, especially where the company had been publicly trading its shares. Such misconduct is unconscionable and another obvious breach of your fiduciary duty to Creative Edge and the other Fiduciaries, and evidence that you are unfit to continue as an Officer and Director of Creative Edge.

Consequently, the above-identified breaches of your fiduciary duty, as well as instances of ultra vires and fraudulent conduct, has put Creative Edge’s very existence in jeopardy. As a result of your unlawful conduct, public trading of Creative Edge’s stock was halted and the Company delisted by the OTC, and the Company still retains the skull and crossbones symbol of delistment. Creative Edge has suffered irreparable economic damage as well as significant damage to its brand and trademark.

In addition, due to the breach of your fiduciary duty, the Group has been forced to expend significant time and funds totaling $9,000.00 paid to Nevada Secretary of State and the OTC to reinstate the company from dissolution and to begin bringing Creative Edge current of financial filings in an effort to lift the “skull and crossbones”.

Your unlawful conduct makes it evident that you are not fit to remain as an officer and director, and the Group hereby demands that:

1) you resign your position(s) as an Officer and as a director of Creative Edge; and,

2) transfer the Super Voting Rights preferred shares transferred to you as CEO in order to maintain control over the Company; and,

3) transfer the trademark and any other mark or intellectual property belonging to Creative; and,

4) pay back the $130,000.00 Investment from the Group, as well as the total amount of money expended by the Group to the State of Nevada and the OTC, as well as other costs expended to cure the company’s filing delinquencies; and

5) returning to the Company any shares of common stock you obtained or gifted unlawfully; and

6) Obtain the resignation of every other present Officer and Director of Creative Edge.

[The above-identified demands are hereafter collectively referred to as the “Demands”]

However, notwithstanding your potential criminal and civil liability to Creative Edge, its shareholders, creditors and the Group for your unlawful conduct, the purpose of this demand is to attempt to amicably resolve the issues created by your fraud and breach of fiduciary duty and bad faith. The only resolution that is appropriate under the current circumstances would be that you comply with all of the Demands by the date identified immediately below. In the event that you refuse to comply with these Demands the Group will cause a shareholder derivative suit to be filed against you individually for the economic loss to the value of Creative Edge, fraud, misrepresentation, punitive damages,and any other damages incurred, as well as contacting all applicable authorities, including, the police, the SEC, FINRA, IRS, and the OTC.

Therefore, the Group hereby demands that you heed and cure all of the above-identified Demands, including reparations to repay the investments and all costs of the group, by close of business Wednesday, July 5, 2017. In the event that you refuse to comply with all demands, the Group will be forced to pursue all Demands identified above, as well as to pursue all other legal remedies available to fully cure your misconduct. We await your response.

Please govern yourself accordingly.

Respectfully yours,


Brian S. Payne

Cc: Nevada Secretary of State, Corp. Division

Nevada Attorney General

OTC Markets

Action Stock Transfer, Inc.

Mr. Keith Landrum, Attorney



********************************

Our intention is to keep moving forward until our demands are met or a reasonable settlement is achieved. Please know that we are planning, willing and able to fix FITX, but the actions of the past few days leave us with a void in terms of next steps. Our committed goals are to restore shareholder value and launch the drink, followed by other products. We will not give up the fight!

Enjoy the rest of the week everyone…its Cold Beverage Season!!!


Brian



PS. James, if you are reading this, give me a call. You have the number.

PPS. Where’s the drink?

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 6

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Flex Acquires EPC Power in a $4.4 Billion Deal

Updated Category News Views 2

An Acquisition with Enormous Implications Folks, if you haven't been paying attention, you're missing out on a seismic shift. EPC Power's sale to Flex for a hefty $4.4 billion isn't just another transaction; it's a clear signal of where the future's headed, especially if you're plugged into the energy or tech sectors. With the way AI is guzzling power like a thirsty...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 3

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Updated Category News Views 1

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Continue Reading
Little Sunshine's Opens New School in Peoria, AZ

Updated Category News Views 2

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...

Continue Reading
LV Petroleum Expands Footprint with Key Acquisitions

Updated Category News Views 2

LV Petroleum's Bold Moves in July Ever seen a company expand across four states in a blink? LV Petroleum's been hustling like a player with a fresh hand of aces. They shut July down with restaurant openings and a fancy new travel center under their belt in states as spread out as Arizona, Texas, Nevada, and Ohio. Now that's a wide net they're casting, all in the name of...

Continue Reading
Innovation Drives New Asia-Pacific Opportunities

Updated Category News Views 0

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 3

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Decoding Historic Home Buys: Tips for New Owners

Updated Category News Views 1

Realities Behind the Rustic Facade Picture this: you’re standing in front of a crumbling beauty with crown molding and character oozing from its very walls. Now what? It's easy to get swept away by the allure of a historic home, but there's gritty work to be done under those charming facades. Enter Debi Beiland of Limestone Properties over in Maysville, KY. She’s got...

Continue Reading
Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Updated Category News Views 2

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Continue Reading

Top 5 Most Recently Viewed Articles

SentirJuntos Review: Should You Sign Up?

Updated Category Business Views 14

This SentirJuntos review covers a platform that draws in users who want a structured way to meet people online rather than scroll through a photo feed hoping someone swipes back. SentirJuntos positions itself around conversation-first interaction — icebreakers, message threads, and member browsing — without the algorithmic matchmaking that defines many competitors....

Continue Reading
Novo Nordisk's Strategic Share Repurchase Program Insights

Updated Category News Views 68

Understanding Novo Nordisk's Share Repurchase Program Novo Nordisk has embarked on an exciting journey by launching a share repurchase program, which reflects its ongoing commitment to enhancing value for shareholders. This initiative, recently introduced, adheres to European regulations aimed at safeguarding investors and upholding market integrity. Current Financial...

Continue Reading
Morgan Stanley Surges on Strong Q3 Earnings Report

Updated Category News Views 41

Morgan Stanley's Impressive Q3 Earnings Performance Morgan Stanley has recently made headlines with its third-quarter earnings for 2024, which notably surpassed analysts’ predictions. This upbeat news has positively influenced the company’s stock performance, triggering a notable 2% rise in premarket trading. This increase can be attributed to the robust performance...

Continue Reading
Exploring the Expansion of the Hair Removal Wax Market Trends

Updated Category News Views 277

Understanding the Growing Hair Removal Wax Market The global hair removal wax market is on the rise, projected to expand by USD 436.4 million within a few years. This transformation highlights the increasing popularity and benefits of hair removal wax products among consumers worldwide. The market's growth isn't just reflected in numbers; it's a shift towards beauty...

Continue Reading
BioIVT and IDBS Collaboration Revolutionizes Research Efficiency

Updated Category News Views 166

Introduction to BioIVT and IDBS Collaboration In a significant step towards enhancing efficiencies in the biopharmaceutical sector, BioIVT, a leading provider of in vitro ADME research services, has collaborated with IDBS to implement the IDBS E-WorkBook platform. This initiative led to a remarkable reduction in study times by at least 30%, marking a transformative moment...

Continue Reading